13F

Stock

Aclaris Therapeutics, Inc.

ACRS · held by 2 managers

Reported value

$60.1K

Holders

2

+0 new · −0 exited

Holders’ est. mark

−$7.65K

Price effect on 2 books still in the name

Largest holder

$44.3K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC40.2K$44.3K−$5.63KCut−$40.4K
Marex Group plc14.4K$15.8K−$2.02KCut−$2.02K

Positions as of Q2 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.